365 related articles for article (PubMed ID: 17269921)
1. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.
Calvagno MG; Celia C; Paolino D; Cosco D; Iannone M; Castelli F; Doldo P; Frest M
Curr Drug Deliv; 2007 Jan; 4(1):89-101. PubMed ID: 17269921
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases.
Cosco D; Paolino D; Cilurzo F; Casale F; Fresta M
Int J Pharm; 2012 Jan; 422(1-2):229-37. PubMed ID: 22093954
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
[TBL] [Abstract][Full Text] [Related]
5. Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes.
Celia C; Calvagno MG; Paolino D; Bulotta S; Ventura CA; Russo D; Fresta M
J Nanosci Nanotechnol; 2008 Apr; 8(4):2102-13. PubMed ID: 18572621
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel-loaded liposomes: The effect of lipid composition and purification on drug encapsulation and in vitro toxicity.
Pereira S; Egbu R; Jannati G; Al-Jamal WT
Int J Pharm; 2016 Nov; 514(1):150-159. PubMed ID: 27863659
[TBL] [Abstract][Full Text] [Related]
7. Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes.
Kim MJ; Lee HJ; Lee IA; Kim IY; Lim SK; Cho HA; Kim JS
Arch Pharm Res; 2008 Apr; 31(4):539-46. PubMed ID: 18449514
[TBL] [Abstract][Full Text] [Related]
8. Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity.
Dalla Pozza E; Lerda C; Costanzo C; Donadelli M; Dando I; Zoratti E; Scupoli MT; Beghelli S; Scarpa A; Fattal E; Arpicco S; Palmieri M
Biochim Biophys Acta; 2013 May; 1828(5):1396-404. PubMed ID: 23384419
[TBL] [Abstract][Full Text] [Related]
9. Effective light-triggered contents release from helper lipid-incorporated liposomes co-encapsulating gemcitabine and a water-soluble photosensitizer.
Fuse T; Tagami T; Tane M; Ozeki T
Int J Pharm; 2018 Apr; 540(1-2):50-56. PubMed ID: 29410222
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells.
Celano M; Calvagno MG; Bulotta S; Paolino D; Arturi F; Rotiroti D; Filetti S; Fresta M; Russo D
BMC Cancer; 2004 Sep; 4():63. PubMed ID: 15363094
[TBL] [Abstract][Full Text] [Related]
11. Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
Xu H; Paxton J; Lim J; Li Y; Zhang W; Duxfield L; Wu Z
Pharm Res; 2014 Oct; 31(10):2583-92. PubMed ID: 24639234
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol derivative-based liposomes for gemcitabine delivery: preparation, in vitro, and in vivo characterization.
Li T; Chen L; Deng Y; Liu X; Zhao X; Cui Y; Shi J; Feng R; Song Y
Drug Dev Ind Pharm; 2017 Dec; 43(12):2016-2025. PubMed ID: 28760000
[TBL] [Abstract][Full Text] [Related]
13. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.
Pili B; Reddy LH; Bourgaux C; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
Nanoscale; 2010 Aug; 2(8):1521-6. PubMed ID: 20820745
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid.
Pasut G; Canal F; Dalla Via L; Arpicco S; Veronese FM; Schiavon O
J Control Release; 2008 May; 127(3):239-48. PubMed ID: 18346806
[TBL] [Abstract][Full Text] [Related]
15. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
16. Effects of lipid composition on the properties of doxorubicin-loaded liposomes.
Sakai-Kato K; Nanjo K; Kawanishi T; Okuda H; Goda Y
Ther Deliv; 2015 Jul; 6(7):785-94. PubMed ID: 26228772
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of gemcitabine liposome injections.
Zhou Q; Liu L; Zhang D; Fan X
Pharmazie; 2012 Oct; 67(10):844-7. PubMed ID: 23136718
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
Tang Z; Feng W; Yang Y; Wang Q
Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity.
Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Özdemir A; Ark M; Takka S
Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]